Literature DB >> 7599788

Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.

A G Fahrenkamp1, C Wibbeke, G Winde, D Ofner, W Böcker, R Fischer-Colbrie, K W Schmid.   

Abstract

The aim of the present study was to investigate immunohistochemically the distribution of chromogranin A, chromogranin B, and secretogranin II in a series of 152 neuroendocrine tumours of the gastrointestinal tract. Tumour tissues from 25 argyrophil gastric carcinoids, 18 gastrin and 5 somatostatin-producing tumours, 4 'gangliocytic paragangliomas', 49 classical argentaffin and 2 L cell appendiceal carcinoids, 27 classical ileal carcinoids, 17 rectal carcinoids, and 5 poorly differentiated neuroendocrine tumours of the stomach and rectum were immunostained with antibodies against chromogranin A, chromogranin B, and secretogranin II. Chromogranin A was the major granin expressed in gastric carcinoids and in serotonin-producing carcinoids of the appendix and the ileum. In contrast, strong chromogranin B and secretogranin II immunoreactivity was found in rectal carcinoids, in which chromogranin A was rarely expressed. Since chromogranin A is a widely used marker for neuroendocrine differentiation, it is of diagnostic importance that some gastrin-producing tumours, 'gangliocytic paragangliomas', poorly differentiated neuroendocrine carcinomas, and appendiceal L cell carcinoids completely lacked chromogranin A positivity. It is concluded that the various neuroendocrine tumours of the gastrointestinal tract show distinctly different patterns of granin expression, probably reflecting their histogenetical origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599788     DOI: 10.1007/BF00191345

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  37 in total

1.  The primary structure of rat secretogranin II deduced from a cDNA sequence.

Authors:  H H Gerdes; E Phillips; W B Huttner
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

2.  Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract.

Authors:  P Facer; A E Bishop; R V Lloyd; B S Wilson; R J Hennessy; J M Polak
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

3.  Specific endocrine tissue marker defined by a monoclonal antibody.

Authors:  R V Lloyd; B S Wilson
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

4.  Ultrastructural localization of chromogranin: a potential marker for the electron microscopical recognition of endocrine cell secretory granules.

Authors:  I M Varndell; R V Lloyd; B S Wilson; J M Polak
Journal:  Histochem J       Date:  1985-09

5.  Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases.

Authors:  C Bordi; J Y Yu; M T Baggi; C Davoli; F P Pilato; G Baruzzi; G Gardini; G Zamboni; G Franzin; M Papotti
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

6.  Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C).

Authors:  R Kirchmair; R Hogue-Angeletti; J Gutierrez; R Fischer-Colbrie; H Winkler
Journal:  Neuroscience       Date:  1993-03       Impact factor: 3.590

7.  A comparative immunohistochemical study of jejunoileal and appendiceal carcinoids. Implications for histogenesis and pathogenesis.

Authors:  T N Moyana; N Satkunam
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

8.  Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study.

Authors:  J Sidhu; R L Sánchez
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

9.  Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues.

Authors:  D T O'Connor; D Burton; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  11 in total

1.  Recurrent small bowel obstruction in an elderly woman.

Authors:  T S Chandrasekar; M Murugesh; M Murthy; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2010-03

Review 2.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 3.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 4.  Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?

Authors:  Andrew M Bellizzi
Journal:  Hum Pathol       Date:  2019-12-17       Impact factor: 3.466

Review 5.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

6.  Immunohistochemical expression of neuroendocrine secretory protein-55 (NESP-55) in pituitary adenomas.

Authors:  Mamta Gupta; Ricardo V Lloyd; Reiner Fischer-Colbrie; Arthur S Tischler; Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

7.  The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.

Authors:  Jamie Koo; Xiaoyan Zhou; Elizabeth Moschiano; Mariza De Peralta-Venturina; Richard B Mertens; Deepti Dhall
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

8.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

9.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

Review 10.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.